4.7 Article

Homoharringtonine induces apoptosis and inhibits STAT3 via IL-6/JAK1/STAT3 signal pathway in Gefitinib-resistant lung cancer cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Cancer Statistics, 2014

Rebecca Siegel et al.

CA-A CANCER JOURNAL FOR CLINICIANS (2014)

Editorial Material Oncology

Afatinib for lung cancer: let there be light?

Marina C. Garassino et al.

LANCET ONCOLOGY (2014)

Review Oncology

The Role of STAT3 in Non-Small Cell Lung Cancer

Daijiro Harada et al.

CANCERS (2014)

Review Pharmacology & Pharmacy

Dacomitinib, a new therapy for the treatment of non-small cell lung cancer

Christina Brzezniak et al.

EXPERT OPINION ON PHARMACOTHERAPY (2013)

Article Cell Biology

Mitochondrial Ca2+ and apoptosis

Carlotta Giorgi et al.

CELL CALCIUM (2012)

Review Cell Biology

STIM proteins: dynamic calcium signal transducers

Jonathan Soboloff et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)

Review Oncology

Antibody therapy of cancer

Andrew M. Scott et al.

NATURE REVIEWS CANCER (2012)

Article Pharmacology & Pharmacy

Suppression of Stat3 activity sensitizes gefitinib-resistant non small cell lung cancer cells

Huan-Chih Chiu et al.

BIOCHEMICAL PHARMACOLOGY (2011)

Article Medicine, Research & Experimental

Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling

Simon A. Jones et al.

JOURNAL OF CLINICAL INVESTIGATION (2011)

Article Multidisciplinary Sciences

Overexpression and Small Molecule-Triggered Downregulation of CIP2A in Lung Cancer

Liang Ma et al.

PLOS ONE (2011)

Review Biochemistry & Molecular Biology

Dangerous liaisons: STAT3 and NF-κB collaboration and crosstalk in cancer

Sergei I. Grivennikov et al.

CYTOKINE & GROWTH FACTOR REVIEWS (2010)

Article Biochemistry & Molecular Biology

Inhibition of STAT3 Signaling Blocks the Anti-apoptotic Activity of IL-6 in Human Liver Cancer Cells

Yan Liu et al.

JOURNAL OF BIOLOGICAL CHEMISTRY (2010)

Article Medicine, General & Internal

Gefitinib or Chemotherapy for Non-Small-Cell Lung Cancer with Mutated EGFR.

Makoto Maemondo et al.

NEW ENGLAND JOURNAL OF MEDICINE (2010)

Article Multidisciplinary Sciences

TGF-β IL-6 axis mediates selective and adaptive mechanisms of resistance to molecular targeted therapy in lung cancer

Zhan Yao et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)

Article Multidisciplinary Sciences

The T790M mutation in EGFR kinase causes drug resistance by increasing the affinity for ATP

Cai-Hong Yun et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Medicine, Research & Experimental

Mutations in the EGFR kinase domain mediate STAT3 activation via IL-6 production in human lung adenocarcinomas

Sizhi Paul Gao et al.

JOURNAL OF CLINICAL INVESTIGATION (2007)

Article Biochemical Research Methods

The development of a bioengineered organ germ method

Kazuhisa Nakao et al.

NATURE METHODS (2007)

Review Pharmacology & Pharmacy

Docetaxel/anthracycline combinations for breast cancer treatment

Gunter von Minckwitz

EXPERT OPINION ON PHARMACOTHERAPY (2007)

Review Oncology

Estimating the world cancer burden: GLOBOCAN 2000

DM Parkin et al.

INTERNATIONAL JOURNAL OF CANCER (2001)

Article Biochemistry & Molecular Biology

Functional analysis of the human MCL-1 gene

C Akgul et al.

CELLULAR AND MOLECULAR LIFE SCIENCES (2000)